Literature DB >> 7570293

Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.

C Barbadillo1, A G-Arroyo, C Salas, J Mulero, F Sánchez-Madrid, J L Andreu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7570293     DOI： 10.1007/BF00196098

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  56 in total

Review 1.  Cell adhesion/signalling: biology and clinical applications.

Authors:  M W Makgoba; A Bernard; M E Sanders
Journal:  Eur J Clin Invest       Date:  1992-07       Impact factor: 4.686

Review 2.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  Leukocyte adhesion to endothelium in inflammation.

Authors:  L Osborn
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.

Authors:  C Herzog; C Walker; W Müller; P Rieber; C Reiter; G Riethmüller; P Wassmer; H Stockinger; O Madic; W J Pichler
Journal:  J Autoimmun       Date:  1989-10       Impact factor: 7.094

5.  Beta 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns.

Authors:  H el Gabalawy; J Wilkins
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

6.  Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis.

Authors:  J C Edwards; L S Wilkinson; P Speight; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

7.  Lymphocytapheresis--a feasible treatment for rheumatoid arthritis.

Authors:  P Emery; G N Smith; G S Panayi
Journal:  Br J Rheumatol       Date:  1986-02

8.  Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

Authors:  G Horneff; G R Burmester; F Emmrich; J R Kalden
Journal:  Arthritis Rheum       Date:  1991-02

9.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin.

Authors:  M R Campanero; R Pulido; M A Ursa; M Rodríguez-Moya; M O de Landázuri; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539
View more
  8 in total

1.  Combinatorial approaches to inhibitors of VLA-4: piperazine-peptoid-bisarylureas.

Authors:  I Lewis; B Rohde; M Mengus; M Weetall; S Maida; R Hugo; P Lake
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

Review 2.  Adhesion molecules in inflammatory diseases.

Authors:  R González-Amaro; F Díaz-González; F Sánchez-Madrid
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

3.  The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.

Authors:  Juping Du; Shuaishuai Chen; Jianfeng Shi; Xiaoli Zhu; Haijian Ying; Ying Zhang; Shiyong Chen; Bo Shen; Jun Li
Journal:  Clin Rheumatol       Date:  2017-09-14       Impact factor: 2.980

4.  Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease.

Authors:  A C Issekutz; L Ayer; M Miyasaka; T B Issekutz
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

5.  Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A.

Authors:  L M Ayer; A C Issekutz; C C Waterhouse; A W Stadnyk
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

Review 6.  Use of biologics in the treatment of childhood rheumatic diseases.

Authors:  T Arkachaisri; T J Lehman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

7.  Hypoxia and hypoxia mimetics inhibit TNF-dependent VCAM1 induction in the 5A32 endothelial cell line via a hypoxia inducible factor dependent mechanism.

Authors:  Todd V Cartee; Kellie J White; Marvin Newton-West; Robert A Swerlick
Journal:  J Dermatol Sci       Date:  2011-10-19       Impact factor: 4.563

Review 8.  Cell-cell interactions in synovitis. Endothelial cells and immune cell migration.

Authors:  Z Szekanecz; A E Koch
Journal:  Arthritis Res       Date:  2000-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.